HDAC9 and glycogen storage disease VI: HDAC inhibitors belong to a large and diverse family of compounds with beneficial effects in a wide range of animal disease models, including glutamate excitotoxicity (Marinova et al. 2009), chronic pain (Wang et al. 2016), and atrial fibrillation (Lkhagva et al. 2016).